2-(benzothiazol-2-yl)-2-(tetrahydro-2-furanyliden)acetonitrile | 654064-80-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 2-(benzothiazol-2-yl)-2-(tetrahydro-2-furanyliden)acetonitrile
• 英文别名: 2-(1,3-benzothiazol-2-yl)-2-(tetrahydro-2-furanyliden)acetonitrile；Benzothiazol-2-yl-(dihydrofuran-2-ylidene)-acetonitrile；2-(1,3-benzothiazol-2-yl)-2-(oxolan-2-ylidene)acetonitrile
• CAS: 654064-80-9
• 化学式: C₁₃H₁₀N₂OS
• 分子量: 242.301
• InChiKey: WVMBDPGFZCDOMN-UHFFFAOYSA-N

物化性质

• 沸点：
  400.1±55.0 °C(Predicted)
• 密度：
  1.364±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  74.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(benzothiazol-2-yl)-2-(tetrahydro-2-furanyliden)acetonitrile 在 盐酸 、 乙醇 、 sodium 作用下， 以 水 为溶剂， 反应 4.0h， 生成 6-amino-5-(benzo[d]thiazol-2-yl)-4-(3-hydroxypropyl)pyrimidine-2(1H)-thione
  参考文献：
  名称：

  新型2,6-二氨基-5-杂芳基嘧啶作为二氢叶酸还原酶抑制剂的合成与评价

  摘要：

  摘要已经开发了通过2-杂芳基-2-（四氢-2-呋喃基）乙腈与am的环转化反应制备6-氨基-5-杂芳基嘧啶衍生物的合成方法。发现一些2,6-二氨基-5-（1,3-苯并噻唑-2-基）嘧啶对人二氢叶酸还原酶显示适度的抑制活性。进行分子对接以评估该系列化合物在酶的活性位点的结合模式。 图形概要

  DOI：

  10.1007/s00706-017-2032-7
• 作为产物：
  描述：

  苯并噻唑-2-乙腈 在 吡啶 、 三乙胺 作用下， 以 1,4-二氧六环 为溶剂， 生成 2-(benzothiazol-2-yl)-2-(tetrahydro-2-furanyliden)acetonitrile
  参考文献：
  名称：

  Reaction of 2-Hetaryl-2-(tetrahydro-2-furanyliden)acetonitriles with 1,3-N,N-Binucleophiles

  摘要：

  The reactions of 2-hetaryl-2-(tetrahydro-2-furanyliden)acetonitriles with 1,3-N,N-binucleophiles have been investigated. The mechanisms of the reactions have been discussed. Domino reactions of 2-hetaryl-2-(tetrahydro-2-furanyliden) acetonitriles with amidines can provide an efficient access to 3-[2-substituted 6-amino-5-hetaryl-4-pyrimidinyl]-1-propanols.

  DOI：

  10.1055/s-0031-1290435

文献信息

• Hydroxypropyl substituted nitrogen bridgehead fused cyanopyridines
  作者：Demyd S. Milokhov、Olga V. Khilya、Alexander V. Turov、Volodymyr V. Medviediev、Oleg V. Shishkin、Yulian M. Volovenko

  DOI：10.1016/j.tet.2013.12.074

  日期：2014.2

  promoted Michael addition of the substituted acetonitriles to 2-hetaryl-2-(tetrahydro-2-furanyliden)acetonitriles followed by ring transformations has provided novel convenient synthetic methods to nitrogen bridgehead fused cyanopyridines bearing hydroxypropyl side chain. The structures of obtained compounds have been established based on NMR spectroscopy investigation and X-ray diffraction data.

  研究了2-杂芳基-2-（四氢-2-呋喃二烯）乙腈与取代乙腈作为C-亲核试剂的反应，并提出了反应机理。碱促进的取代基乙氧基到2-杂芳基-2-（四氢-2-呋喃腈）乙腈的迈克尔加成反应，然后进行环转化，为带有羟基丙基侧链的氮桥头稠合氰基吡啶提供了新颖便捷的合成方法。基于NMR光谱学研究和X射线衍射数据，已经建立了获得的化合物的结构。
• Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
  申请人：Zhang Zaihui

  公开号：US20060247210A1

  公开（公告）日：2006-11-02

  Pharmaceutical pyrazolybenzothiazole compositions of formula (1) are provided. The compositions may be pharmaceutically acceptable salts. R 1 , R 2 and R 3 at each occurrence are independently selected from amino, aminosulfinyl, aminosulfonyl, aryl, azido, halogen, heteroalkyl, heteroaryl, hydrazinyl, hydrocarbyl, hydrogen, hydroxyl, nitro, nitroso, phosphate, phosphinate, phosphonate, phosphonium, phosphorothioate, phosphoryl, sulfamoyl, sulfate, sulfinic acid, sulfonamido, sulfonate, sulfonic acid, sulfonyl, sulfoxido, thiol, thioureido, and ureido, and R 4 is selected from hydrogen, heteroalkyl, heteroaryl, and hydrocarbyl.

  提供了公式（1）的药用吡唑基苯并噻唑类化合物。这些化合物可以是药用可接受的盐。每次出现的R1，R2和R3均独立地从氨基，氨基亚磺酰基，氨基磺酰基，芳基，偶氮基，卤素，杂基烷基，杂环基，肼基，烃基，氢，羟基，硝基，亚硝基，磷酸盐，磷酸酯，膦酸盐，膦酸铵，磷代硫酸盐，磷酰基，磺酰胺基，硫酸盐，亚磺酸，磺酸，磺酰基，亚磺酰基，硫醇基，硫脲基和脲基中独立选择，而R4从氢，杂基烷基，杂环基和烃基中选择。
• PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
  申请人：Zhang Zaihui

  公开号：US20110178126A1

  公开（公告）日：2011-07-21

  Pharmaceutical compositions and compounds are provided. The compounds of the invention have use as therapeutic agents, e.g., they demonstrate anti-proliferative, anti-inflammatory, anti-angiogenic, anti-migration activities. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of, e.g., anti-inflammatory, renal, and hyperproliferative disorders. The compounds of the invention are pyrazolylbenzothiazole derivatives of the following formula (1) wherein X, R 1 , R 2 , R 3 and R 4 are described herein.

  本发明提供了制药组合物和化合物。该发明的化合物可用作治疗剂，例如，它们表现出抗增殖、抗炎、抗血管生成、抗迁移活性。在本发明的一种实施例中，提供了与生理可接受载体结合的化合物配方。制药配方在治疗抗炎、肾脏和高增殖性疾病方面是有用的。本发明的化合物是以下式(1)的吡唑基苯并噻唑衍生物，其中X、R1、R2、R3和R4如本文所述。
• Synthesis of 2-(2-hetaryl)-6-hydroxy-3-(R-amino)-2-hexenenitriles
  作者：O. V. Khilya、T. A. Volovnenko、A. V. Turov、R. I. Zubatyuk、O. V. Shishkin、Yu. M. Volovenko

  DOI：10.1007/s10593-013-1208-2

  日期：2013.3

  The reaction of 2-hetaryl-2-(tetrahydrofuran-2-ylidene)acetonitriles and 6-chloro-2-(2-hetarylidene)-3-oxohexanenitriles with amines was studied. It was shown that the reaction of primary aliphatic amines with 6-chloro-2-(2-hetarylidene)-3-oxohexanenitriles takes place through a stage involving the formation of 2-hetaryl-2-(tetrahydrofuran-2-ylidene)acetonitriles followed by opening of the furanylidene fragment of the latter and the formation of 2-(2-hetaryl)-6-hydroxy-3-(R-amino)-2-hexenenitriles.
• Reactions of 2-(2-hetaryl)-2-(tetrahydrofuran-2-ylidene)acetonitriles with tertiary amines
  作者：D. S. Milokhov、O. V. Khilya、A. V. Turov、R. I. Zubatyuk、G. V. Palamarchuk、O. V. Shishkin、A. A. Chekotilo、Yu. M. Volovenko

  DOI：10.1007/s10593-013-1207-3

  日期：2013.3

  The reactions of 2-(2-hetaryl)-2-(tetrahydrofuran-2-ylidene)acetonitriles with conformationally rigid and heterocyclic tertiary amines were investigated. Compounds with bipolar structures were obtained: 1-cyano-1-(2-hetaryl)-5-(pyridinium-1-yl)-1-penten-2-olates and 5-(4-aza-1-azoniobicyclo[2.2.2]oct-1-yl)-1-cyano-1-(2-hetaryl)pent-1-en-2-olates.